Azathioprine (Imuran)
An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
Also Known As:
Imuran; Azathioprine Sodium; Azathioprine Sodium Salt; Azathioprine Sulfate; Azothioprine; Immuran; Imurel; Sodium, Azathioprine; 1H-Purine, 6-((1-methyl-4-nitro-1H-imidazol-5-yl)thio)-
Networked: 6170
relevant articles (840 outcomes,
641 trials/studies)
Relationship Network
Drug Context: Research Results
Experts
1. | Sandborn, William J:
24 articles
(07/2022 - 01/2002)
|
2. | de Boer, Nanne K H:
21 articles
(12/2022 - 04/2005)
|
3. | Pagnoux, Christian:
19 articles
(11/2023 - 09/2003)
|
4. | Mulder, Chris J J:
19 articles
(09/2023 - 01/2003)
|
5. | Gisbert, Javier P:
19 articles
(01/2019 - 06/2003)
|
6. | Guillevin, Loïc:
15 articles
(11/2023 - 02/2008)
|
7. | Rutgeerts, Paul:
15 articles
(08/2015 - 02/2002)
|
8. | van Bodegraven, Adriaan A:
14 articles
(06/2023 - 06/2006)
|
9. | Choe, Yon Ho:
13 articles
(11/2022 - 12/2010)
|
10. | Peyrin-Biroulet, Laurent:
13 articles
(07/2022 - 12/2008)
|
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures